NCT06043674 2026-01-07Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's TransformationDana-Farber Cancer InstitutePhase 2 Recruiting70 enrolled